Full text is available at the source.
Abstract
Tirzepatide is associated with substantial weight loss in adults with obesity.
- The efficacy of tirzepatide may differ between Asian and non-Asian adults.
- Ethnic variations in obesity phenotype and cardiometabolic risk could influence treatment outcomes.
- This systematic review and meta-analysis focused on adults without diabetes.
Simplified